Clinical Trial Update: Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of spatial repellents to control cutaneous leishmaniasis in northeast Syria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis Cutaneous

Drugs mentioned

• Spatial repellents (spatial repellents)

Snippet

Sponsor: The Mentor Initiative | Conditions: Leishmaniasis, Cutaneous, Vector Borne Diseases | Phase 3 | Status: COMPLETED